VGLL4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.401800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.917160E-01
Normal-vs-Stage2
6.302400E-01
Normal-vs-Stage3
5.319800E-01
Normal-vs-Stage4
9.669600E-01
Stage1-vs-Stage2
9.457700E-02
Stage1-vs-Stage3
6.543400E-01
Stage1-vs-Stage4
4.808100E-02
Stage2-vs-Stage3
7.566400E-01
Stage2-vs-Stage4
1.583620E-01
Stage3-vs-Stage4
3.565200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.439200E-01
Normal-vs-AfricanAmerican
4.109000E-01
Normal-vs-Asian
4.205200E-01
Caucasian-vs-AfricanAmerican
9.856000E-01
Caucasian-vs-Asian
7.010600E-01
AfricanAmerican-vs-Asian
7.484200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.366400E-01
Normal-vs-Female
2.790000E-01
Male-vs-Female
7.122800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.616600E-01
Normal-vs-Age(41-60Yrs)
6.925800E-01
Normal-vs-Age(61-80Yrs)
2.532400E-01
Normal-vs-Age(81-100Yrs)
5.149400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.308600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.363200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.280400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.382100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.321020E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.328200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.608000E-01
Normal-vs-Daily Drinker
1.814790E-01
Normal-vs-Weekly Drinker
7.237200E-01
Normal-vs-Occasional Drinker
3.007400E-01
Normal-vs-Social Drinker
3.660600E-01
Non Drinker-vs-Daily Drinker
5.665800E-01
Non Drinker-vs-Weekly Drinker
1.066590E-01
Non Drinker-vs-Occasional Drinker
8.905200E-01
Non Drinker-vs-Social Drinker
6.246400E-01
Daily Drinker-vs-Weekly Drinker
6.399800E-02
Daily Drinker-vs-Occasional Drinker
5.445000E-01
Daily Drinker-vs-Social Drinker
3.648200E-01
Weekly Drinker-vs-Occasional Drinker
2.019200E-01
Weekly Drinker-vs-Social Drinker
3.206000E-01
Occasional Drinker-vs-Social Drinker
7.594000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.869600E-01
Normal-vs-Grade 2
7.216200E-01
Normal-vs-Grade 3
7.130800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.14530000000246E-05
Grade 1-vs-Grade 3
3.209600E-04
Grade 1-vs-Grade 4
9.869600E-01
Grade 2-vs-Grade 3
8.445600E-01
Grade 2-vs-Grade 4
7.216200E-01
Grade 3-vs-Grade 4
7.130800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.949400E-01
Normal-vs-NonDiabetic
2.465000E-01
Diabetic-vs-NonDiabetic
8.306000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.746000E-01
Normal-vs-NoPancreatitis
2.520000E-01
Pancreatitis-vs-NoPancreatitis
2.602000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.899630E-01
Normal-vs-N1
6.420400E-01
N0-vs-N1
1.331590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.278200E-01
Normal-vs-TP53-NonMutant
8.471800E-02
TP53-Mutant-vs-TP53-NonMutant
1.402400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
